The resistance toward TKIs in GIST is mainly related to secondary mutations of KIT (Li & Raut, 2019; Napolitano & Vincenzi, 2019), but can also be triggered by PDGFRA mutations (Lim et al, 2008; Kalfusova et al, 2019). Here, PDGFRA is linked to gastrointestinal stromal tumor.